Spire Wealth Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Spire Wealth Management's HALO Position: Q3 2026 in Review
Spire Wealth Management increased its Halozyme (HALO) stake by 8.5% in Q3 2026, buying an estimated $58.3K and bringing the position to 7,748 shares worth $855K. The position accounts for 0.03% of the portfolio, ranked #413.
Spire Wealth Management first reported a position in HALO in Q1 2021 and has held it in 21 quarters since. The position peaked at $7.18M in Q2 2022. 773 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Spire Wealth Management held 7,748 shares of Halozyme worth $855K as of Q3 2026.
- Spire Wealth Management bought 604 Halozyme shares in Q3 2026, an estimated $58.3K.
- Halozyme made up 0.03% of Spire Wealth Management's portfolio in Q3 2026, its #413 holding.
- Spire Wealth Management first reported a position in Halozyme in Q1 2021 and has held it in 21 quarters since.
- Spire Wealth Management's Halozyme position peaked at $7.18M in Q2 2022.
- 773 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Spire Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.